Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays
Titel:
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays
Auteur:
Gupta, Yash Maciorowski, Dawid Zak, Samantha E. Jones, Krysten A. Kathayat, Rahul S. Azizi, Saara-Anne Mathur, Raman Pearce, Catherine M Ilc, David J. Husein, Hamza Herbert, Andrew S. Bharti, Ajay Rathi, Brijesh Durvasula, Ravi Becker, Daniel P. Dickinson, Bryan C. Dye, John M. Kempaiah, Prakasha